![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 15598-15608, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From The Derald H. Ruttenberg Cancer Center, Mount Sinai School of
Medicine, New York, New York 10029
An important regulator of the proapoptotic
BAX is the tumor suppressor protein p53. Unlike the
p21 gene, in which p53-dependent transcriptional activation is mediated by a response element containing two consensus p53 half-sites, it previously was reported that activation of the BAX element by p53 requires additional
sequences. Here, it is demonstrated that the minimal BAX
response element capable of mediating p53-dependent
transcriptional activation consists of two p53 half-sites plus an
adjacent 6 base pairs (5'-GGGCGT-3'). This GC-rich region constitutes a
"GC box" capable both of binding members of the Sp family of
transcription factors, including Sp1 in vitro, and of
conferring Sp1-dependent transcriptional activation on a
minimal promoter in cells. Mutations within this GC box abrogated the
ability of p53 to activate transcription without affecting the affinity
of p53 for its binding site, demonstrating that these 6 bases are
required for p53-dependent activation. In addition, a
positive correlation was observed between the ability of p53 to
activate transcription in cells and the ability of Sp1 to bind this
response element in vitro. Mutations that inhibited Sp1
binding also blocked the ability of p53 to activate transcription
through this element. Together, these results suggest a model in which p53 requires the cooperation of Sp1 or a Sp1-like factor to mediate transcriptional activation of the human BAX promoter.
The Tumor Suppressor Protein p53 Requires a Cofactor to Activate
Transcriptionally the Human BAX Promoter*
*
This work was supported by NCI Grant CA69161 from the
National Institutes of Health and the Breast Cancer Program of the
United States Army Medical Research and Materiel Command Grants
DAMD-17-97-1-7336, DAMD-17-97-1-7337, and DAMD-17-99-1-9308).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Cancer Center, Box
1130, Mount Sinai School of Medicine, New York, NY 10029. Tel.: 212-659-5495; Fax: 212-849-2446.
This article has been cited by other articles:
![]() |
L. Smeenk, S. J. van Heeringen, M. Koeppel, M. A. van Driel, S. J. J. Bartels, R. C. Akkers, S. Denissov, H. G. Stunnenberg, and M. Lohrum Characterization of genome-wide p53-binding sites upon stress response Nucleic Acids Res., June 1, 2008; 36(11): 3639 - 3654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fan, H. Ren, N. Jia, E. Fei, T. Zhou, P. Jiang, M. Wu, and G. Wang DJ-1 Decreases Bax Expression through Repressing p53 Transcriptional Activity J. Biol. Chem., February 15, 2008; 283(7): 4022 - 4030. [Abstract] [Full Text] [PDF] |
||||
![]() |
L L Loro, A C Johannessen, and O K Vintermyr Loss of BCL-2 in the progression of oral cancer is not attributable to mutations J. Clin. Pathol., November 1, 2005; 58(11): 1157 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Torigoe, H. Izumi, T. Wakasugi, I. Niina, T. Igarashi, T. Yoshida, I. Shibuya, K. Chijiiwa, K.-i. Matsuo, H. Itoh, et al. DNA Topoisomerase II Poison TAS-103 Transactivates GC-Box-dependent Transcription via Acetylation of Sp1 J. Biol. Chem., January 14, 2005; 280(2): 1179 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Kurata, T. Okuyama, M. Osada, T. Watanabe, Y. Tomimori, S. Sato, A. Iwai, T. Tsuji, Y. Ikawa, and I. Katoh p51/p63 Controls Subunit {alpha}3 of the Major Epidermis Integrin Anchoring the Stem Cells to the Niche J. Biol. Chem., November 26, 2004; 279(48): 50069 - 50077. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Porras, S. Zuluaga, E. Black, A. Valladares, A. M. Alvarez, C. Ambrosino, M. Benito, and A. R. Nebreda p38{alpha} Mitogen-activated Protein Kinase Sensitizes Cells to Apoptosis Induced by Different Stimuli Mol. Biol. Cell, February 1, 2004; 15(2): 922 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sola, X. Ma, R. E. Castro, B. T. Kren, C. J. Steer, and C. M. P. Rodrigues Ursodeoxycholic Acid Modulates E2F-1 and p53 Expression through a Caspase-independent Mechanism in Transforming Growth Factor {beta}1-induced Apoptosis of Rat Hepatocytes J. Biol. Chem., December 5, 2003; 278(49): 48831 - 48838. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Buzek, L. Latonen, S. Kurki, K. Peltonen, and M. Laiho Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277 Nucleic Acids Res., June 1, 2002; 30(11): 2340 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. O. Karpinich, M. Tafani, R. J. Rothman, M. A. Russo, and J. L. Farber The Course of Etoposide-induced Apoptosis from Damage to DNA and p53 Activation to Mitochondrial Release of Cytochrome c J. Biol. Chem., May 3, 2002; 277(19): 16547 - 16552. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Im, M. R. Pittelkow, and R. Kumar Divergent Regulation of the Growth-promoting Gene IEX-1 by the p53 Tumor Suppressor and Sp1 J. Biol. Chem., April 19, 2002; 277(17): 14612 - 14621. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Watanabe, T. Ozaki, T. Nakagawa, K. Miyazaki, M. Takahashi, M. Hosoda, S. Hayashi, S. Todo, and A. Nakagawara Physical Interaction of p73 with c-Myc and MM1, a c-Myc-binding Protein, and Modulation of the p73 Function J. Biol. Chem., April 19, 2002; 277(17): 15113 - 15123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stros, T. Ozaki, A. Bacikova, H. Kageyama, and A. Nakagawara HMGB1 and HMGB2 Cell-specifically Down-regulate the p53- and p73-dependent Sequence-specific Transactivation from the Human Bax Gene Promoter J. Biol. Chem., February 22, 2002; 277(9): 7157 - 7164. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Klein, G. Georges, K.-P. Kunkele, R. Huber, R. A. Engh, and S. Hansen High Thermostability and Lack of Cooperative DNA Binding Distinguish the p63 Core Domain from the Homologous Tumor Suppressor p53 J. Biol. Chem., September 28, 2001; 276(40): 37390 - 37401. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Koutsodontis, I. Tentes, P. Papakosta, A. Moustakas, and D. Kardassis Sp1 Plays a Critical Role in the Transcriptional Activation of the Human Cyclin-dependent Kinase Inhibitor p21WAF1/Cip1 Gene by the p53 Tumor Suppressor Protein J. Biol. Chem., July 27, 2001; 276(31): 29116 - 29125. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |